Your browser doesn't support javascript.
loading
Susceptibility of Clostridium species isolated in Japan to fidaxomicin and its major metabolite OP-1118.
Yanagihara, Katsunori; Akamatsu, Norihiko; Matsuda, Junichi; Kaku, Norihito; Katsumata, Kiyomitsu; Kosai, Kosuke.
Afiliación
  • Yanagihara K; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: k-yanagi@nagasaki-u.ac.jp.
  • Akamatsu N; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: akmatsu@nagasaki-u.ac.jp.
  • Matsuda J; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: jmatsuda@nagasaki-u.ac.jp.
  • Kaku N; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: kaku-n@nagasaki-u.ac.jp.
  • Katsumata K; Department of Drug Discovery Research, Astellas Pharma, Inc., 21, Miyukigaoka, Tsukuba, Ibaraki, Japan. Electronic address: kiyomitsu.katsumata@astellas.com.
  • Kosai K; Department of Laboratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Electronic address: k-kosai@nagasaki-u.ac.jp.
J Infect Chemother ; 24(6): 492-495, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29373265

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Clostridium / Aminoglicósidos / Antiinfecciosos Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Clostridium / Aminoglicósidos / Antiinfecciosos Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article